PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Tumor budding: A predictor for metastasis in the CAM xenograft model (2019) Muenzner JK, Ranjan RA, Eckstein M, Erber R, Kunze P, Geppert CI, Rübner M, et al. Conference contribution Protein levels of Piwi-like 1 and-2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients (2019) Eckstein M, Jung R, Weigelt K, Sikic D, Stöhr R, Geppert CI, Agaimy A, et al. Conference contribution New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story? (2019) Eckstein M, Gupta S Journal article, Editorial Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go (2019) Gevaert T, Cimadamore A, Eckstein M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R Journal article, Review article Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays (2019) Eckstein M, Sailer V, Nielsen BS, Wittenberg T, Wiesmann V, Lieb V, Nolte E, et al. Journal article, Original article The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes (2019) Pfannstiel C, Strissel P, Chiappinelli KB, Sikic D, Wach S, Wirtz RM, Wullweber A, et al. Journal article Re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538–40 (2019) Gevaert T, Eckstein M, Montironi R, Lopez-Beltran A Journal article Automatic Detection of Tumor Buds in Pan-Cytokeratin Stained Colorectal Cancer Sections by a Hybrid Image Analysis Approach (2019) Bergler M, Benz M, Rauber D, Hartmann D, Kötter M, Eckstein M, Schneider-Stock R, et al. Conference contribution, Conference Contribution Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts (2019) Sikic D, Wirtz RM, Wach S, Dyrskjot L, Erben P, Bolenz C, Breyer J, et al. Journal article Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC) (2019) Spachmann PJ, Azzolina V, Weber F, Evert M, Eckstein M, Denzinger S, Burger M, et al. Journal article